Next-generation cancer drugs boost immunotherapy responses – Nature.com
Nature.com |
Next-generation cancer drugs boost immunotherapy responses
Nature.com An approach to unleashing immune responses against cancer is showing promise in early clinical trials, and may boost the effectiveness of existing therapies. The experimental drugs target a protein called IDO, which starves immune cells by breaking … |
